InsidersTradesSigma
Follow the アンジェス株式会社 stock price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares are listed on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, アンジェス株式会社 has recorded 41 insider filings. Market capitalisation: €18.6bn. The latest transaction was reported on 4 September 2026 (Holding update). Among the most active insiders: Cantor Fitzgerald Europe. Every trade is free.
41
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,511 of 29,065 companies
16.3
score / 100
Value6
Quality26
FCF yld-38%
Earn yld-34%
EV/EBITDA·
ROE-215%
Gross mgn37%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 September 2026
Declarations41 total
ShareXTKSEDINET:S100Z0NF
0.8% of flowShareXTKSEDINET:S100XF2G
0.8% of flowShareXTKSEDINET:S100X7SU
32.6% of flowShareXTKSEDINET:S100WLRX
100.0% of flowShareXTKSEDINET:S100WK0C
ShareXTKSEDINET:S100WJK5
0.3% of flowShareXTKSEDINET:S100WDVR
0.3% of flowShareXTKSEDINET:S100WA6O
0.4% of flowShareXTKSEDINET:S100VV37
0.5% of flowShareXTKSEDINET:S100VTGP
0.5% of flowShareXTKSEDINET:S100VMZU
0.6% of flowShareXTKSEDINET:S100VG4F
0.6% of flowShareXTKSEDINET:S100VDMJ
0.7% of flowShareXTKSEDINET:S100VC7Q
0.8% of flowShareXTKSEDINET:S100V8LU
0.8% of flowShareXTKSEDINET:S100V713
1.1% of flowShareXTKSEDINET:S100UX07
1.2% of flowShareXTKSEDINET:S100UM3E
1.3% of flowShareXTKSEDINET:S100ULVH
1.5% of flowShareXTKSEDINET:S100UJEJ
1.6% of flowShareXTKSEDINET:S100UHFP
0.3% of flowShareXTKSEDINET:S100TZNB
0.3% of flowShareXTKSEDINET:S100TPF9
0.4% of flowShareXTKSEDINET:S100TNS6
0.4% of flowShareXTKSEDINET:S100TIZF
25 of 41 declarations
关于 アンジェス株式会社
AnGes, Inc. 是一家专注于健康和制药领域的公司，专门从事基因疗法和疫苗的开发。该公司在 XTKS 市场上市。